Productivity and temperature biology of two snowbed bryophytes

Summary Chlorophyll distribution within the carpets, CO₂ gas exchange under controlled conditions, and heat resistance of the snowbed bryophyte Anthelia juratzkana (Limpr.) Trev. were investigated. Also the gas-exchange parameters of the co-occurring Polytrichum sexangulare Floercke were assessed. Only the uppermost 4 mm layer of Anthelia carpets contains sufficient pigments for photosynthesis. At light saturation and optimal temperatures (6–11°C) the maximum rates of CO₂ uptake are 0.7 mg CO₂ g^-1dw h^-1 in Anthelia and 1.5 mg CO₂ g^-1dw h^-1 in Polytrichum. Gas exchange reaches light saturation at about 300 E m^-2s^-1 in both species. At +2°C the light compensation point is reached at ca. 10E m^-2s^-1 and increases significantly with increasing temperature. The lower temperature compensation point is reached at-4°C in Anthelia and does not drop much below-5°C in Polytrichum. Anthelia cannot sustain net photosynthesis beyond 30°C and Polytrichum not beyond 32°C. Nine month storage under dark, cold and wet conditions does not affect the photosynthetic capability of Anthelia. As a response, however, the net photosynthesis rate is depressed due to an increase of the respiration rates. Polytrichum sexangulare did not tolerate the storage so well. The heat resistance limit of Anthelia is low (39°C). There is evidence that the distribution of the two bryophytes within snowbed communities is determined by their capability to make use of low light intensities and their low temperature demand for optimal photosynthetic rates. Being resistant to long lasting cold, wet, and dark conditions, Anthelia is particularly adapted to grow in the border zone along permanent snowpatches. Polytrichum is more productive and is therefore capable of competing successfully at sites which are less extreme and therefore accessible for higher plants.     

Studies in the mechanism of phenylethylamine uptake by rabbit erythrocytes

The mechanism of phenylethylamine (PEA) uptake by in vitro rabbit erythrocyte preparations involve both a larger component of passive diffusion and an Na+-dependent facilitated transport system. This is reflected by the fast rate and lack of saturation of PEA erythrocyte uptake, and by the decrease in PEA tissue/medium ratio when the amine was incubated in an Na+-free medium or in the presence of ouabain. Results obtained after the addition of iodoacetamide or by the use of glucose-free medium suggest the Na+-K+ gradient as the driving force responsible for operation of the carrier mechanism. Preliminary results indicate that amphetamine PEA share a similar mechanism for their uptake by rabbit erythrocytes. At the levels normally present in rabbit blood (c. 1 X 10(-8)M), about one-third of the PEA is found in the serum and only a very small portion of it (less than 1%) is present as the "biologically active" non-ionized amine. Most of the remaining phenylethylamine is bound to plasma protein or inside the erythrocytes.     

Soluble inhibitory factor (SIF) in normal human serum

We have previously noted that dividing T cells release soluble inhibitory factor (SIF) into culture fluids. SIF was distinguished from most other suppressor factors by consisting of two components: a protein and a glycolipid, lipid suppressor substance (LSS). We had noted large quantities of LSS in serum of a patient with a cutaneous lymphoma. This prompted the present study in which SIF was found in normal human serum in a fraction derived by ethanol precipitation. The SIF complex reduced uptake of [³H]thymidine into mixed leukocyte culture (MLC) by 77%. SIF from serum (SIF-serum) resembled SIF in culture fluids (SIF-sup) by chromatography and function at all stages of purification. LSS was extracted from SIF-serum, as measured by an 88% reduction of [³H]thymidine incorporation into phytohemagglutinin-stimulated lymphocytes. The apparent MW of SIF was between 100, 000 and 150, 000. LSS from serum was purified by two-dimensional thin-layer chromatography to apparent homogeneity. The presence of SIF in normal human serum suggests that it may have an in vivo role in immune regulation.     

Drug residue formation from ronidazole, a 5-nitroimidazole. II. Involvement of microsomal NADPH-cytochrome P-450 reductase in protein alkylation in vitro

Purified liver microsomal NADPH-cytochrome P-450 reductase is able to catalyze the activation of [14C]ronidazole to metabolite(s) which bind covalently to protein. Like the reaction catalyzed by microsomes, protein alkylation catalyzed by the reductase is (1) sensitive to oxygen, (2) requires reducing equivalents, (3) is inhibited by sulfhydryl-containing compounds and (4) is stimulated several fold by either flavin mononucleotide (FMN) or methytlviologen. A cytochrome P-450 dependent pathway of ronidazole activation can be demonstrated as judged by the inhibition of the reaction by carbon monoxide, metyrapone and 2,4-dichloro-6-phenylphenoxyethylamine but the involvement of specific microsomal cytochrome P-450 isozymes has not been definitively established. Milk xanthine oxidase is also capable of catalyzing ronidazole activation. Polyacrylamide sodium dodecyl sulfate (SDS)-gel electrophoresis reveals that the reactive intermediate(s) of ronidazole does not alkylate proteins selectively.     

Drug residue formation from ronidazole, a 5-nitroimidazole. III. Studies on the mechanism of protein alkylation in vitro

Ronidazole (1-methyl-5-nitroimidazole-2-methanol carbamate) is reductively metabolized by liver microsomal and purified NADPH-cytochrome P-450 reductase preparations to reactive metabolites that covalently bind to tissue proteins. Kinetic experiments and studies employing immobilized cysteine or blocked cysteine thiols have shown that the principal targets of protein alkylation ara cysteine thiols. Furthermore, ronidazole specifically radiolabelled with 14C in the 4,5-ring, N-methyl or 2-methylene positions give rise to equivalent apparent covalent binding suggesting that the imidazole nucleus is retained in the bound residue. In contrast, the carbonyl-14C-labeled ronidazole gives approx. 6--15-fold less apparent covalent binding indicating that the carbamoyl group is lost during the reaction leading to the covalently bound metabolite. The conversion of ronidazole to reactive metabolite(s) is quantitative and reflects the amazing efficiency by which this compound is activated by microsomal enzymes. However, only about 5% of this metabolite can be accounted for as protein-bound products under the conditions employed in these studies. Consequently, approx. 95% of the reactive ronidazole metabolite(s) can react with other constituents in the reaction media such as other thiols or water. Based on these results, a mechanism is proposed for the metabolic activation of ronidazole.     

Phospholipid distribution and stimulation of methylation during denervation and reinnervation in skeletal muscle

Denervation of the rat soleus and extensor digitorum longus muscles was induced by nerve crush. Functional signs of denervation were noted within 48 h with recovery beginning about the 12th day following denervation. There was also a marked decrease in muscle weight but only a small decrease in protein content per mg of muscle, subsequent to denervation. At 1, 2 and 3 weeks following nerve crush there was a relative decrease in muscle phosphatidylethanolamine (PE) and a corresponding increase in phosphatidylcholine (PC). The proportion of the other phospholipids did not significantly change. The levels of PC and PE returned to, or in some cases slightly overshot, control values at 4 and 5 weeks following nerve crush, i.e. during the period of reinnervation. Levels in non-denervated contralateral muscles did not significantly change. At 1 and 3 weeks following nerve crush a marked increase was observed in the activities of the enzymes PE-methyltransferases I and II, as measured by [³H]methyl group incorporation from S-adenosyl methionine into phosphatidylmonomethylethanolamine, phosphatidyldimethylethanolamine and PC. Increased activity of these methylases was seen in the contralateral control muscle, although less than in the denervated muscle. These enzymatic changes could be responsible for the changes in PE and PC distribution which we observed. Methylation of PE might also decrease the microviscosity of the membrane, thereby leading to other changes associated with denervation. Activation of this system might be another form of supersensitivity induced by denervation.     

Biochemical characterization of propionyl CoA carboxylase deficiency: Heterogeneity within a single genetic complementation group

Liver tissues and fibroblasts from patients with propionic acidemia assigned to the pcc BC genetic complementation group have previously been shown to contain normal or near-normal quantities of structurally altered propionyl CoA carboxylases (PCC). Biochemical comparisons of PCCs from extracts of three livers and one placenta belonging to the pcc BC complementation group revealed that the K _m values for the enzyme's major substrates, propionyl CoA, bicarbonate, and ATP, and its monovalent activator, potassium, were similar to those of normal PCC. PCC in extracts of one of the livers, however, had an altered isoelectric point (pI = 5.4) compared to that of PCC from normal and other PCC-deficient tissues (pK = 4.6–4.7). Thermostability in the presence of sucrose or ATP differed among several of the mutant PCCs, including the PCC with an altered pI, and from that of normal PCC. To confirm these results and to determine whether valid inferences may be derived from comparisons of mutant and normal PCC in crude extracts, PCC was purified from normal liver and from one of the PCC-deficient livers. The biochemical parameters of the purified carboxylases were similar to those observed in liver extracts. These studies further-more confirmed that, whether purified or in extracts, PCC from the pcc BC group reflects structural mutations. Nevertheless, the abnormal enzyme structure appears to have no corresponding effect on the clinical features of the disorder in various affected individuals. Moreover, there is biochemical heterogeneity within the pcc BC complementation group that probably represents different interallelic gene mutations.This work was supported by NIH Research Grants Am 25675 and AM 26127. B. Wolf is the recipient of NIH Research Career Development Award AM 00677 and is aided by Basil O'Connor Starter Research Grant 5-263 from The National Foundation-March of Dimes. This article is No. 131 from the Department of Human Genetics at the Medical College of Virginia.     

Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells.

Previously we have reported the purification and characterization of a novel cytokine from an EBV-transformed B cell line, RPMI 8866. This factor, termed natural killer cell stimulatory factor (NKSF), possessed pleiotropic activities including the induction of IFN-gamma from PBL, enhancement of cytotoxicity by NK cells, and stimulation of the proliferation of PBL. Purified NKSF was found to be a disulfide-linked heterodimeric protein composed of 35-kDa and 40-kDa subunits (p35 and p40). We now report the molecular cloning of cDNA for both subunits of NKSF from RPMI 8866 cellular RNA. The cDNA sequences indicate that both genes are novel, and Southern blot analysis confirmed that both cDNA are of human genomic origin. [35S]Methionine labeling indicated that cos-1 cells transfected with either p35 or p40 cDNA produced unique protein species of appropriate size. Methionine labeling of cos-1 cells cotransfected with p35 plus p40 cDNA yielded a broad band migrating between 70 and 90 kDa on a nonreducing gel. Reduction of this high molecular weight material yielded bands correlating with p35 and p40 gene products. Only culture supernatant from cotransfected cos-1 cells had a high level of NKSF biologic activity. That the high molecular weight material was responsible for this activity was indicated by the observation that biologic activity in the culture supernatant migrated at 70 to 90 kDa in a nonreducing gel. Furthermore, anti-p40 serum was able to block the biologic activities of both recombinant and natural NKSF, which indicates that it is a component of the active protein. In contrast, no activity could be detected in the supernatants of cos-1 cells transfected with p40 or p35 cDNA alone. The spectrum of biologic activity produced by cotransfected cos-1 cells was the same as NKSF purified to homogeneity from the RPMI 8866 cell line. A synergistic augmentation of some of these responses was found by the addition of IL-2 or the co-stimulators PHA or phorbol diester. The synergistic stimulation by NKSF plus IL-2 of T and NK function supports the possibility that these cytokines might prove useful in cancer therapy.     

Carboxypeptidase yscS: gene structure and function of the vacuolar enzyme

The gene encoding carboxypeptidase yscS in Saccharomyces cerevisiae, CPS1, was cloned by complementation of the cps1-3 mutation. The cloned CPS1 gene, which again enabled a leucine auxotrophic cps1-3 mutant to grow on the modified dipeptide Cbz-Gly-Leu (Cbz, benzyloxycarbonyl) as sole leucine source, was sequenced and found to consist of an open reading frame of 1728 bp encoding a protein of 576 amino acids. The putative protein contains a hydrophobic stretch of 20 amino acids and a putative signal sequence cleavage site. Five putative N-glycosylation sites are also in the protein sequence. This data is consistent with the previous finding of carboxypeptidase yscS being a vacuolar peptidase. Chromosomal disruption of the CPS1 gene completely abolishes carboxypeptidase yscS activity. This protein is yet another member of the peptidases in S. cerevisiae involved in nitrogen metabolism.